Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Theseus Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 599K | $1.83M | $3.05 | Oct 12, 2021 | Indirect |
Verve Therapeutics, Inc. | 10%+ Owner | Common Stock | 153K | $1.53M | $10.00 | Jun 21, 2021 | Indirect |
Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 1.26M | $1.04M | $0.83 | Oct 26, 2021 | Indirect |
Tempest Therapeutics, Inc. | 10%+ Owner | Common Stock | 73.7K | $352K | $4.78 | Dec 30, 2021 | Indirect |
Theseus Pharmaceuticals, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | Oct 12, 2021 | Indirect | ||
Verve Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jun 21, 2021 | Indirect | ||
Xilio Therapeutics, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | Oct 26, 2021 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TPST | Tempest Therapeutics, Inc. | Dec 30, 2021 | 0 | $0 | 3 | Jan 10, 2022 | 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Oct 26, 2021 | 5 | $8M | 4 | Oct 26, 2021 | 10%+ Owner |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | 10%+ Owner |
THRX | Theseus Pharmaceuticals, Inc. | Oct 12, 2021 | 5 | $4M | 4 | Oct 14, 2021 | 10%+ Owner |
THRX | Theseus Pharmaceuticals, Inc. | Oct 6, 2021 | 0 | $0 | 3 | Oct 6, 2021 | 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 21, 2021 | 5 | $7.03M | 4 | Jun 22, 2021 | 10%+ Owner |
VERV | Verve Therapeutics, Inc. | Jun 16, 2021 | 0 | $0 | 3 | Jun 16, 2021 | 10%+ Owner |